Webinars
We want to help you discover just how much you can benefit from using mass spectrometry for HCP analysis and ELISA coverage analysis. Therefore, below you have access to a number of short on-demand webinars – which you can watch when it suits your schedule.
LC-MS quantifying HCPs: Experimental USP 1132.1 method comparison
41:00
Protect your mAb stability: Control polysorbate-degrading host cell HCPs
47:12
USP initiatives enhancing the quality of MS-based HCP analysis
47:56
mAb HCP Control Strategy Part II: Experiences from an “off-ELISA” road
43:47
mAb HCP Control Strategy Part I: Experiences from an “off-gel” road
39:32
Ensure process efficiency and consistency w. data from 500 projects
58:55
Exclusive Q&A with Bryant McLaughlin, CMC Executive, USA
33:03
Webinar: Problematic HCP impurities can stop your biologics project!
45:13
ELISA reagent characterization using advanced LC-MS methods
44:09
LC-MS HCP assay validation and GMP release testing for complex samples
50:34
Analyzing vaccine purity – without an HCP ELISA
46:45
Moving LC-MS analysis into a GMP environment
39:46
The Principles of Mass Spec for HCP Analysis
22:50
How to monitor impurities and ensure consistent gene therapies
34:45
3 reasons to check the coverage of your HCP-ELISA
33:10
#Rethink your
HCP strategy
33:30
Comparison of impurity profiles – and problematic HCPs – in mAbs
35:39
Are you ready for FDA questions about impurities?
35:39
Why do we need orthogonal HCP analysis for mAbs?
24:42
HCP analysis using LC-MS – for data-driven process development
30:48
Design the optimal strategy for analyzing Host Cell Proteins
32:13
Talk to us
Whatever protein-related challenge or question you may have, we would love to help. Our experts can help you decide on the best analytical approach for your project by email or online meeting - providing advice without obligation.